You've been on semaglutide (Ozempic or Wegovy), and now you're considering switching to tirzepatide (Mounjaro or Zepbound). Maybe you've plateaued. Maybe you want the greater weight loss tirzepatide offers. Maybe your insurance changed.
Whatever the reason, switching between these medications requires some planning. Done right, it's smooth. Done wrong, you can face unnecessary side effects or gaps in treatment.
Here's the complete guide to making the transition.
Why Switch?
Common reasons people switch from semaglutide to tirzepatide:
- Greater efficacy: Tirzepatide produces ~20% weight loss vs ~15% for semaglutide
- Plateau: Weight loss has stalled on semaglutide
- Side effects: Some people tolerate one better than the other
- Insurance/cost: Coverage or pricing changed
- Additional indications: Tirzepatide is FDA-approved for sleep apnea
- Better blood sugar control: For those with diabetes, tirzepatide may be more effective
The Key Principles
Critical rule: There is no direct dose equivalency between semaglutide and tirzepatide. They are different medications with different mechanisms. You cannot simply "convert" your dose.
Both medications activate GLP-1 receptors, but tirzepatide also activates GIP receptors. The receptor binding profiles, half-lives, and dosing scales are different. Trying to find an "equivalent" dose doesn't work and isn't safe.
The Switching Protocol
No Washout Period Required
You don't need to stop semaglutide for weeks before starting tirzepatide. The half-lives are similar (~5-7 days), and there's no dangerous interaction between them.
Time Your Last Semaglutide Dose
Take your last semaglutide injection as scheduled. Then wait approximately one week (your normal injection day) before taking your first tirzepatide dose.
Always Start at 2.5mg Tirzepatide
Regardless of what semaglutide dose you were on—even if you were at 2.4mg Wegovy—always start tirzepatide at 2.5mg. This is the standard starting dose for everyone.
Follow Standard Titration
Increase tirzepatide dose every 4 weeks as tolerated: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg. Don't rush because you were on a high semaglutide dose.
What to Expect During Transition
Week 1: The Gap
During the week between your last semaglutide and first tirzepatide:
- Appetite may increase slightly as semaglutide clears your system
- This is normal and temporary
- Don't panic—it doesn't mean you'll regain weight in one week
- Stick to your eating patterns
Early Tirzepatide: GI Adjustment
Even though you're experienced with GLP-1 medications, you may experience some GI symptoms with tirzepatide:
- The GIP component is new to your system
- Different receptor activation patterns
- Nausea, constipation, or diarrhea possible (usually mild)
- Typically less severe than when you first started semaglutide
Weight Response
What happens to your weight during transition varies:
- Some people see immediate additional loss as tirzepatide kicks in
- Others maintain briefly then resume losing
- A small increase during the gap week is possible but usually water weight
- Long-term trajectory should improve with tirzepatide's greater efficacy
Common Mistakes to Avoid
Mistake #1: Starting tirzepatide at a high dose because you were on high-dose semaglutide. This causes unnecessary side effects. Always start at 2.5mg.
Mistake #2: Overlapping medications—taking both in the same week. This can intensify side effects with no additional benefit.
Mistake #3: Rushing titration because you're "used to" GLP-1s. Tirzepatide is a different medication. Respect the titration schedule.
Mistake #4: Panicking during the gap week and eating significantly more. One week without medication won't undo your progress if you maintain habits.
Titration Schedule Reference
| Week | Tirzepatide Dose | Notes |
|---|---|---|
| 1-4 | 2.5mg | Starting dose for everyone |
| 5-8 | 5mg | First maintenance option |
| 9-12 | 7.5mg | Continue if needed |
| 13-16 | 10mg | Mid-range dose |
| 17-20 | 12.5mg | Continue if needed |
| 21+ | 15mg | Maximum dose |
You may not need to reach 15mg. Many people achieve goals at lower doses. Titrate based on response and tolerability, not a predetermined endpoint.
If You Have Diabetes
Special considerations for people switching while managing diabetes:
- Monitor blood sugar closely during transition
- Tirzepatide is more potent for glucose control—hypoglycemia risk may increase
- Discuss insulin adjustments with your provider if applicable
- Don't stop diabetes monitoring just because weight is the primary goal
Switching the Other Direction
Less common, but some people switch from tirzepatide to semaglutide (usually for cost/insurance reasons). The same principles apply:
- Take last tirzepatide dose as scheduled
- Wait approximately one week
- Start semaglutide at 0.25mg or 0.5mg (not max dose)
- Titrate up normally
Note: you may experience some weight regain when switching to the less effective medication, even at equivalent relative doses.
Questions to Ask Your Provider
- Is switching appropriate for my situation?
- Are there any specific considerations given my health conditions?
- How will we handle the prior authorization for the new medication?
- When should I schedule a follow-up after starting tirzepatide?
- Should any of my other medications be adjusted?
The Bottom Line
Switching from semaglutide to tirzepatide is straightforward:
- Take your last semaglutide dose
- Wait one week
- Start tirzepatide at 2.5mg
- Titrate up every 4 weeks as tolerated
- Expect some GI adjustment but likely less than your initial GLP-1 experience
The most important point: always start tirzepatide at the beginning dose, regardless of where you were on semaglutide. The medications aren't interchangeable, and there's no dose conversion chart. Start fresh, titrate normally, and you'll likely see improved results with tirzepatide's greater efficacy.
Ready to Switch?
Find providers who can help you transition between GLP-1 medications.
Compare Providers